HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CIR Experts Close Book (For Now) On Parabens: Safe Individually Or At Sum Concentration Of ≤0.8%

Executive Summary

NGO Women’s Voices for the Earth supports the 0.8% limit on total parabens content adopted by the Cosmetic Ingredient Review Expert Panel at its 16-17 September meeting. WVE remains concerned, however, about certain assumptions made by the panel in the lengthy re-review process that led to its final amended report.

You may also be interested in...



New York Cosmetic Ingredient Bill Still In Committee With Clock Running Out

New York continues chasing California in its efforts to increase regulation of the cosmetic products sector.

EU’s Addition Of Butylparaben To SVHC List Won’t Impact Cosmetics Use … Or Will It?

Cosmetic uses of substances of very high concern are excluded from authorization requirements under EU REACH when the substance was listed strictly for endocrine-disrupting concerns. However, cosmetic product manufacturers may find the preservative unavailable from suppliers should butylparaben eventually make the European Chemicals Agency’s Authorization List.

California Bill Advances To Ban Cosmetic Ingredients Prohibited In EU, With PCPC’s Backing

The California Toxic-Free Cosmetics Act passed out of the State Assembly Committee on Environmental Safety and Toxic Materials on 14 May. A far cry from the original draft of the bill, AB 2762 would ban more than a dozen cosmetic ingredients in California whose use is prohibited already in Europe.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

RS149231

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel